Clinical Trial Update: Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating epacadostat with a vaccine therapy in patients with stage III-IV melanoma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma
• Mucosal Melanoma
• Uveal Melanoma

Drugs mentioned

• Epacadostat (epacadostat)
• Vaccine therapy

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Mucosal Melanoma, Recurrent Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-02-07